Key Points
- Director Kurt Kuehn sold 2,844 shares at an average price of $78.96 for proceeds of $224,562.24, trimming his stake by 15.57% to 15,420 shares; the transaction was disclosed in an SEC filing.
- Henry Schein beat quarterly estimates—EPS $1.34 vs. $1.30 and revenue $3.44B vs. $3.34B—set FY2026 guidance of 5.230–5.370 EPS, and carries an average analyst rating of "Hold" with a $85.58 target.
Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) Director Kurt Kuehn sold 2,844 shares of the company's stock in a transaction that occurred on Tuesday, March 10th. The shares were sold at an average price of $78.96, for a total value of $224,562.24. Following the transaction, the director directly owned 15,420 shares of the company's stock, valued at $1,217,563.20. This trade represents a 15.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
Henry Schein Stock Performance
Shares of Henry Schein stock traded up $0.30 on Thursday, reaching $76.80. 139,339 shares of the company were exchanged, compared to its average volume of 1,405,306. The firm has a market cap of $8.81 billion, a price-to-earnings ratio of 23.44, a P/E/G ratio of 2.26 and a beta of 0.88. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $89.29. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.76 and a current ratio of 1.38. The company's 50-day moving average is $78.25 and its two-hundred day moving average is $72.77.
Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, February 24th. The company reported $1.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.30 by $0.04. The business had revenue of $3.44 billion during the quarter, compared to analyst estimates of $3.34 billion. Henry Schein had a return on equity of 15.16% and a net margin of 3.02%.The business's revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.19 EPS. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of research firms recently weighed in on HSIC. Leerink Partners reaffirmed a "market perform" rating on shares of Henry Schein in a report on Monday. Mizuho boosted their target price on shares of Henry Schein from $81.00 to $88.00 and gave the company a "neutral" rating in a research note on Wednesday, February 25th. Wells Fargo & Company upped their target price on shares of Henry Schein from $76.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Wednesday, February 25th. Weiss Ratings restated a "hold (c)" rating on shares of Henry Schein in a research note on Monday, December 29th. Finally, Barclays began coverage on Henry Schein in a research note on Monday, December 8th. They set an "overweight" rating and a $86.00 target price on the stock. Six investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $85.58.
Check Out Our Latest Analysis on Henry Schein
Institutional Trading of Henry Schein
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. CYBER HORNET ETFs LLC acquired a new stake in shares of Henry Schein in the 2nd quarter worth approximately $25,000. MUFG Securities EMEA plc acquired a new position in shares of Henry Schein during the second quarter valued at approximately $27,000. Flagship Harbor Advisors LLC acquired a new position in shares of Henry Schein during the fourth quarter valued at approximately $30,000. Federated Hermes Inc. bought a new stake in Henry Schein during the fourth quarter worth approximately $32,000. Finally, Los Angeles Capital Management LLC bought a new stake in Henry Schein during the fourth quarter worth approximately $37,000. 96.62% of the stock is currently owned by institutional investors.
About Henry Schein
(
Get Free Report)
Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.
In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
